STUDY OF THE AMINO ACID COMPOSITION OF SOYBEAN PROTEIN FRACTIONS
The role of soy protein in the development of obesity should not be underestimated, given its status as a major component, the
presence of bioactive compounds, and its high biological value. Moreover, soy protein consumption in both diabetic and non-
diabetic individuals reduces kidney damage and inflammation by lowering the glomerular filtration rate and improving creatinine
clearance, opening up potential opportunities for its use as a therapeutic agent for chronic kidney disease. A diet rich in soluble
fiber reduces carbohydrate absorption and lowers plasma glucose concentrations in diabetics. Similarly, studies have shown that
soy fiber intake enhances fecal bile excretion and reduces fat absorption, thereby providing protection against hyperglycemia.
1. Choi CW, Choi YH, Cha MR, Yoo DS, Kim YS, Yon GH, Hong KS, Kim YH, Ryu SY (2010) Yeast α-glucosidase inhibition
by isoflavones from plants of Leguminosae as an in vitro alternative to acarbose. J Agric Food Chem 58(18):9988–9993
2. D’Aloisio AA, DeRoo LA, Baird DD, Weinberg CR, Sandler DP (2013) Prenatal and infant exposures and age at menarche.
Epidemiology (Cambridge, MA) 24(2):277
3. Dia VP, Berhow MA, Gonzalez De Mejia E (2008) Bowman birk inhibitor and genistein among soy compounds that
synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages. J Agric Food
Chem 56(24):11707–11717
4. Dong JY, Qin LQ, Zhang Z, Zhao Y, Wang J, Arigoni F, Zhang W (2011) Effect of oral L-arginine supplementation on blood
pressure: a meta-analysis of randomized, double-blind, placebo- controlled trials. Am Heart J 162(6):959–965
5. Dudek SG (2013) Nutrition essentials for nursing practice. Lippincott Williams & Wilkins, Philadelphia, PA
6. Escurriol V, Cofán M, Moreno-Iribas C, Larrañaga N, Martínez C, Navarro C, Rodríguez L, González CA, Corella D, Ros
E (2010) Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort. J Lipid Res
51(3):618–624
7. Huang H, Krishnan HB, Pham Q, Yu LL, Wang TT (2016b) Soy and gut microbiota: interaction and implication for human
health. J Agric Food Chem 64(46):8695-8709
8. Huang H, Krishnan HB, Pham Q, Yu LL, Wang TT (2016b) Soy and gut microbiota: interaction and implication for human
health. J Agric Food Chem 64(46):8695-8709
9. Hymowitz T. On the domestication of the soybean. /T. Hymowitz/ Economic Botany. — 1970. — Vol. 24. — №. 4. — P.
408-421.
10. Jackson RL, Greiwe JS, Schwen RJ (2011) Emerging evidence of the health benefits of S-equol, an estrogen receptor β
agonist. Nutr Rev 69(8):432-448
11. Karimov I.A. Qishloq xo’jaligi taraqqiyoti – to’kin hayot manbai. T.:
12. Kobayashi M, Egusa S, Fukuda M (2014) Isoflavone and protein constituents of lactic acid- fermented soy milk combine to
prevent dyslipidemia in rats fed a high cholesterol diet. Nutrients 6(12):5704–5723
13. Krogdahl, A. Soybean proteinase inhibitors and human proteolitic en-zimes. Selective inactivation of inhibitors by treatment
with human gastric juice / A. Krogdahl, H. Holm // J. Nutr. — 1981. — Vol. 111. — P. 2045-2051. "Glycine max".
Encyclopedia of Life. Retrieved February 16, 2012.
14. Kwon DY, Daily JW III, Kim HJ, Park S (2010) Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr
Res 30(1):1-3
15. Latorraca MQ, da Costa RP, Laux MC, da Rosa CA, Arantes VC, de Barros Reis MA (2019) Effects of the soybean flour
diet on insulin secretion and action. In: Preedy VR, Watson RR (eds) Flour and breads and their fortification in health and
disease prevention. Academic Press, London, pp 423–434
Copyright (c) 2026 «ACTA NUUz»
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
.jpg)
1.png)
